CClinicalTrials.gg
CompletedNCT05365295TDAH-DRMUpdated Sep 19, 2025

Study of ADHD Children's Sensitivity to Memory Error Production

An interventional study of DRM (Deese, Roediger et McDermott task) in ADHD, sponsored by University Hospital, Angers. Completed at 2 sites in France. Open to participants aged 8 Years to 11 Years. Per ClinicalTrials.gov, last updated 2025-09-19.

Sponsored by University Hospital, Angers · Not applicable, Interventional, and Screening

Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Not applicable
Ages
8 Years to 11 Years
Sex
All
01

Study summary

The purpose of the study is to test whether children with Attention Deficit/Hyperactivity Disorder (ADHD) are more susceptible to false memory production using a DRM paradigm. The number of "critical decoy production" errors will be analyzed and compared to the calibration of the test.

Read the detailed description

During a neuropsychological assessment, as part of the clinical routine, children with a diagnosis of ADHD, without neurological etiology, aged 8 to 10 years will be offered an additional task. This task, a DRM adapted to the child, consists of learning several lists of words. Each list exposes words belonging to the same lexical field, to a concept not explicitly mentioned in the list, called critical lure. Immediately after the presentation of a list, the child is asked to recall as many words as possible. Recall of the critical lure gives an indication of the production of false memories. The number of critical lures produced by these children will be compared to the calibration of the test, currently being published. The investigator will also verify if the production of critical lures can be correlated with other variables such as performance on intellectual, executive and attentional tasks, proposed during the clinical routine assessment.

The investigator hypothesize that ADHD children will recall more critical lures than the norm, and fewer correct responses than the norm.

The data collected is taken from the child's psychological file. The only personal information used, beyond test performance, is the child's gender and age. The procedure is anonymous.

02

Conditions studied

03

In context

Attention Deficit Disorder with Hyperactivity

1,514 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 255 are open to participants now.

This study's enrollment of 28 is below the median of 72 across 1,207 interventional studies indexed under Attention Deficit Disorder with Hyperactivity.

Browse Attention Deficit Disorder with Hyperactivity studies →

Lead sponsor

University Hospital, Angers is the lead sponsor of 464 studies on the registry; 116 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age between 96 and 131 months
  • Child referred by a doctor for a neuropsychological assessment
  • Child with ADHD diagnosis
  • Sufficient command of the French language
  • Non-opposition of the child and his/her parents

Exclusion criteria

Exclusion Criteria:

  • Severe psychiatric comorbidity: major depressive episode, bipolar disorder, generalized anxiety disorder, autism spectrum disorder
  • Major neurological history: severe head trauma, stroke, severe epilepsy, brain tumor
  • Repeating a class during school
  • Presence of an intellectual disability
  • Use of methylphenidate treatment less than 48 hours before the experiment
  • Completion of an intellectual assessment using the Wechsler Intelligence Scale for Children (WISC-V) dated less than one year before the meeting
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
28 participants (actual)

Study arms

  • Experimental
    ADHD

    \- ADHD children aged between 8 to 10 years old

    Other: DRM (Deese, Roediger et McDermott task)

Interventions

  • OtherDRM (Deese, Roediger et McDermott task)

    Eight lists of nine words are presented to the participants. Each list is heard once. Immediately afterwards, the child is asked to recall the words he or she remembers. Each child's response is then repeated one by one and the participant is asked to rate his or her confidence in the response on a five-point scale (from "not at all sure" to "100% sure"). A 5-minute break is given in the middle of the task, after the first four lists are presented. The test takes about 20 minutes.

06

What researchers measure

Primary outcomes

  1. DRM (Deese-Roediger-McDermott task) Performance 1

    correct answers

    Time frame: 20 minutes during DRM DRM (Deese-Roediger-McDermott) task

  2. DRM (Deese-Roediger-McDermott task) Performance 2

    critical lures

    Time frame: 20 minutes during DRM DRM (Deese-Roediger-McDermott) task

  3. DRM (Deese-Roediger-McDermott task) Performance 3

    intruders associated with the lexical field

    Time frame: 20 minutes during DRM DRM (Deese-Roediger-McDermott) task

  4. DRM (Deese-Roediger-McDermott task) Performance 4

    non-associated intruders

    Time frame: 20 minutes during DRM DRM (Deese-Roediger-McDermott) task

  5. DRM (Deese-Roediger-McDermott task) Performance 5

    average confidence index for each type of answer

    Time frame: 20 minutes during DRM DRM (Deese-Roediger-McDermott) task

07

Study locations

2 sites
  • neuropediatrics department - university hospital center of Angers
    Angers, France
  • Multidisciplinary liberal practice - Acropole Santé
    Rezé, France
08

References and documents

Individual participant data

Plan to share: Yes — Data will be shared upon reasonable request. Only de-identified data will be shared. Any data collected during the study may be shared. The protocol will be shared initially. Other documents may be shared at a later date upon request (e.g., the CRF to allow a collaborator to select the data they wish to access). The recipients of the data will be researchers. The data will be available for any purpose deemed relevant by the study investigator, based on a protocol provided by the requester, after verification of the obtaining of regulatory approvals, including the favorable opinion of an ethics committee.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05365295
Lead sponsor
University Hospital, Angers
Responsible party
Sponsor
First posted
May 9, 2022
Start date
Jun 28, 2022
Primary completion
Oct 17, 2022
Completion
Oct 17, 2022
Last update
Sep 19, 2025

Study contacts

Pierre Martin
principal investigator · UH Angers

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion